Grindeks is the leading pharmaceutical manufacturer in Baltic States, headquartered in Riga, Latvia and operating since 1946.
Over the years we have been recognized for helping millions of patients worldwide. Our products are sold in 103 countries globally. Grindeks product portfolio is successfully composed of original products, generics, and active pharmaceutical ingredients, all produced in line with the world-class requirements of safety and quality.
To help people overcome their health issues, we focus on the heart and cardiovascular, CNS, anti-cancer, and anti-diabetes medicines. We aim to improve people's lives and make health solutions accessible to our patients.
Today Grindeks Group consists of JSC Grindeks and its subsidiaries. Each one of them is contributing to the growth of the Group and being an integral part of the corporation. At this moment, we are on course to establish many more subsidiaries across the globe; their purpose being getting us a better insight in their respective country, increasing a value for patients and availability of our products. We offer our medicines under two brand names – Grindeks and Kalceks; the reason is that each specializes in different customer segment.
JSC Kalceks based in Latvia, is one of the oldest pharmaceutical companies in the Baltic States, specializing in generics mostly for the hospital segment. HBM Pharma Ltd., based in Slovakia, is a pharmaceutical product manufacturer and operates in the field of producing injectable ampules and tablets. JSC Tallinn Pharmaceutical Plant, based in Estonia, produces ointments.
Grindeks Kalceks are our newest subsidiaries established in Lithuania, Estonia, the United States of America, Canada, Switzerland, and Poland. Namu apsaimniekosanas projekti is responsible for managing Grindeks real estate.